Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases

Hwa Jeong You, Jae Hyon Park, Helios Pareja-Galeano, Alejandro Lucia, Jaeil Shin

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Neurodegenerative diseases are becoming an ever-increasing problem in aging populations. Low levels of brain-derived neurotrophic factor (BDNF) have previously been associated with the pathogenesis of numerous neurodegenerative diseases. Recently, microRNAs (miRNAs) have been proposed as potential novel therapeutic targets for treating various diseases of the central nervous system (CNS), and interestingly, few studies have reported several miRNAs that downregulate the expression levels of BDNF. However, substantial challenges exist when attempting to translate these findings into practical anti-miRNA therapeutics, especially when the targets remain inside the CNS. Thus, in this review, we summarize the specific molecular mechanisms by which several miRNAs negatively modulate the expressions of BDNF, address the potential clinical difficulties that can be faced during the development of anti-miRNA-based therapeutics and propose strategies to overcome these challenges.

Original languageEnglish
Pages (from-to)540-550
Number of pages11
JournalNeuroMolecular Medicine
Volume18
Issue number4
DOIs
Publication statusPublished - 2016 Dec 1

Fingerprint

Brain-Derived Neurotrophic Factor
MicroRNAs
Neurodegenerative Diseases
Central Nervous System Diseases
Therapeutics
Down-Regulation
Central Nervous System
Population

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

You, Hwa Jeong ; Park, Jae Hyon ; Pareja-Galeano, Helios ; Lucia, Alejandro ; Shin, Jaeil. / Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases. In: NeuroMolecular Medicine. 2016 ; Vol. 18, No. 4. pp. 540-550.
@article{8bff93e415d044209a6012d460580858,
title = "Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases",
abstract = "Neurodegenerative diseases are becoming an ever-increasing problem in aging populations. Low levels of brain-derived neurotrophic factor (BDNF) have previously been associated with the pathogenesis of numerous neurodegenerative diseases. Recently, microRNAs (miRNAs) have been proposed as potential novel therapeutic targets for treating various diseases of the central nervous system (CNS), and interestingly, few studies have reported several miRNAs that downregulate the expression levels of BDNF. However, substantial challenges exist when attempting to translate these findings into practical anti-miRNA therapeutics, especially when the targets remain inside the CNS. Thus, in this review, we summarize the specific molecular mechanisms by which several miRNAs negatively modulate the expressions of BDNF, address the potential clinical difficulties that can be faced during the development of anti-miRNA-based therapeutics and propose strategies to overcome these challenges.",
author = "You, {Hwa Jeong} and Park, {Jae Hyon} and Helios Pareja-Galeano and Alejandro Lucia and Jaeil Shin",
year = "2016",
month = "12",
day = "1",
doi = "10.1007/s12017-016-8407-9",
language = "English",
volume = "18",
pages = "540--550",
journal = "NeuroMolecular Medicine",
issn = "1535-1084",
publisher = "Humana Press",
number = "4",

}

Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases. / You, Hwa Jeong; Park, Jae Hyon; Pareja-Galeano, Helios; Lucia, Alejandro; Shin, Jaeil.

In: NeuroMolecular Medicine, Vol. 18, No. 4, 01.12.2016, p. 540-550.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases

AU - You, Hwa Jeong

AU - Park, Jae Hyon

AU - Pareja-Galeano, Helios

AU - Lucia, Alejandro

AU - Shin, Jaeil

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Neurodegenerative diseases are becoming an ever-increasing problem in aging populations. Low levels of brain-derived neurotrophic factor (BDNF) have previously been associated with the pathogenesis of numerous neurodegenerative diseases. Recently, microRNAs (miRNAs) have been proposed as potential novel therapeutic targets for treating various diseases of the central nervous system (CNS), and interestingly, few studies have reported several miRNAs that downregulate the expression levels of BDNF. However, substantial challenges exist when attempting to translate these findings into practical anti-miRNA therapeutics, especially when the targets remain inside the CNS. Thus, in this review, we summarize the specific molecular mechanisms by which several miRNAs negatively modulate the expressions of BDNF, address the potential clinical difficulties that can be faced during the development of anti-miRNA-based therapeutics and propose strategies to overcome these challenges.

AB - Neurodegenerative diseases are becoming an ever-increasing problem in aging populations. Low levels of brain-derived neurotrophic factor (BDNF) have previously been associated with the pathogenesis of numerous neurodegenerative diseases. Recently, microRNAs (miRNAs) have been proposed as potential novel therapeutic targets for treating various diseases of the central nervous system (CNS), and interestingly, few studies have reported several miRNAs that downregulate the expression levels of BDNF. However, substantial challenges exist when attempting to translate these findings into practical anti-miRNA therapeutics, especially when the targets remain inside the CNS. Thus, in this review, we summarize the specific molecular mechanisms by which several miRNAs negatively modulate the expressions of BDNF, address the potential clinical difficulties that can be faced during the development of anti-miRNA-based therapeutics and propose strategies to overcome these challenges.

UR - http://www.scopus.com/inward/record.url?scp=84969902327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969902327&partnerID=8YFLogxK

U2 - 10.1007/s12017-016-8407-9

DO - 10.1007/s12017-016-8407-9

M3 - Review article

VL - 18

SP - 540

EP - 550

JO - NeuroMolecular Medicine

JF - NeuroMolecular Medicine

SN - 1535-1084

IS - 4

ER -